EIS Continuous Glucose Sensor Calibration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current continuous glucose monitoring (CGM) sensors face challenges in assessing viability post-insertion due to potential damage, biofouling, and movement issues, which affect accuracy and require frequent calibration.
Innovation Solution
An electrochemical impedance spectroscopy (EIS) enabled sensor system that monitors the condition of subcutaneously insertable sensors by comparing in vivo capacitance values to reference values, allowing for real-time calibration adjustments to maintain accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If CGM sensors are inserted subcutaneously for continuous monitoring, then continuous glucose data can be obtained, but sensor damage, biofouling, and movement occur during/after insertion affecting accuracy
Solution Approach 1:
The patent applies preliminary action by performing electrochemical impedance spectroscopy (EIS) measurements during the insertion process and immediately after insertion to assess sensor membrane integrity before the sensor begins its monitoring function. This early assessment allows detection of insertion-related damage or biofouling events, enabling timely calibration adjustments or sensor replacement before accuracy degradation occurs.
Solution Approach 2:
The patent implements feedback by continuously monitoring EIS parameters (capacitance, resistance) of the sensor membrane and comparing them against reference values or calibration profiles. When deviations indicate biofouling or damage, the system provides feedback to adjust calibration parameters or alert the user, maintaining reliable glucose measurements despite in vivo challenges.
2Measurement precision
If sensor calibration is performed frequently to maintain accuracy, then measurement precision is improved, but loss of time and increased device complexity occur
Solution Approach 1:
The patent applies self-service by enabling the sensor system to automatically perform EIS-based self-diagnosis and self-calibration. The system autonomously assesses its own membrane condition through impedance measurements and adjusts its calibration profile without requiring manual user intervention, thereby maintaining measurement precision while eliminating time-consuming manual calibration procedures.
Solution Approach 2:
The patent utilizes parameter changes by monitoring variations in EIS parameters (capacitance C, resistance R) that correlate with membrane integrity and biofouling states. By detecting these parameter changes and mapping them to calibration adjustments, the system dynamically adapts its measurement parameters to maintain accuracy without frequent manual recalibration.
3Difficulty of detecting and measuring
If EIS monitoring is implemented to assess sensor condition, then sensor viability detection is improved, but device complexity increases
Solution Approach 1:
The patent applies universality by designing the EIS measurement system to serve multiple functions: it characterizes glucose levels, assesses membrane integrity, detects biofouling events, and provides calibration data all through a single impedance spectroscopy measurement. This multi-functionality improves sensor condition detection capability while minimizing the addition of separate diagnostic devices or procedures.
Solution Approach 2:
The patent uses EIS measurements as an intermediary that indirectly probes sensor membrane condition and biofouling states without requiring direct physical access to or manipulation of the sensor membrane. The impedance parameters serve as mediators that translate complex biological and physical changes into quantifiable electrical signals that indicate sensor viability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The EIS system effectively determines sensor integrity and adjusts calibration profiles to prevent biofouling and movement-related errors, enhancing the accuracy and longevity of CGM sensors.
Implementation Method 1
performing electrochemical impedance spectroscopy on the in vivo sensor to obtain an in vivo parameter value
Implementation Method 2
the in vivo electrochemical impedance spectroscopy test results can be compared to a previously obtained reference test result to determine whether, for example, the sensor has been inserted properly, has been damaged or otherwise compromised, or is intact
Data Source
AI summary
The use of electrical impedance spectroscopy to adjust calibration settings in an in vivo monitoring system, such as an in vivo continuous glucose monitoring sensor. The adjustments can compensate for the condition of the sensor membrane in vivo.